GPT Healthcare Limited
NSE: GPTHEALTH · Hospital · sector
₹129.93NSE close 2026-10-26
Key numbers
Market cap₹1,066 cr
Price₹129.93
52w high / low₹175 / ₹115
P/E22.6xSector median 42.5x
P/B4.0xSector median 4.9x
Book value₹32.8
Dividend yield1.92%Sector median 0.17%
ROE18.3%Sector median 12.1%
ROCE24.4%Sector median 13.8%
OPM18.5%Sector median 20.3%
Debt / equity0.06xSector median 0.24x
EV/EBITDA11.4xSector median 23.6x
Interest cover7.9x
Current ratio1.12x
Sales growth 3y–Sector median +14.1%
Profit growth 3y–Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹47 cr vs borrowings ₹16 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 7.9x in the last 12 months.
- Operating cash flow was below net profit in 0 of the last 3 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 14% of net profit in the last 12 months.
- Dividend paid in 2 of the last 3 financial years.
- Price ₹129.93 on 2026-10-26: -25.8% from the 52-week high, +13.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹186.25 · low ₹118.85
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 106 | 102 | 101 | 107 | 119 | 120 | 126 | 126 |
| EBITDA | 23 | 21 | 21 | 17 | 23 | 21 | 23 | 24 |
| OPM % | 22.2% | 20.8% | 20.4% | 16.2% | 19.1% | 17.2% | 18.5% | 19.2% |
| Other income | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| Net profit | 15 | 12 | 13 | 8 | 11 | 9 | 15 | 13 |
| EPS (₹) | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 | 1.55 |
| Revenue YoY | +12.5% | +17.6% | +24.6% | +17.8% | ||||
| Profit YoY | -28.5% | -23.5% | +13.0% | +65.8% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 400 | 407 | 473 | 492 |
| EBITDA | 88 | 83 | 84 | 91 |
| Net profit | 48 | 50 | 42 | 47 |
| EPS (₹) | 5.96 | 6.08 | 5.15 | 5.76 |
| Revenue growth | +1.7% | +16.1% | +18.1% | |
| Profit growth | +4.5% | -15.4% | -0.8% | |
| Dividend / share (₹) | – | 3.50 | 2.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | +18.1% |
| Net profit | – | – | -0.8% |
| EPS | – | – | – |
| Share price | – | -9.5% (2y) | -11.4% |
Balance sheet
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Shareholders' equity | 218 | 248 | 269 |
| Borrowings | 12 | 13 | 16 |
| Cash & equivalents | 20 | 36 | 47 |
| Total assets | 346 | 384 | 465 |
| Fixed assets | 201 | 203 | 265 |
| Capital work in progress | 6 | 46 | 1 |
| Investments | 19 | 0 | 0 |
| Receivables | 24 | 25 | 20 |
| Inventory | 8 | 9 | 11 |
| Payables | 37 | 35 | 42 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash from operations | 69 | 67 | 81 |
| Cash from investing | -25 | -33 | -47 |
| Cash from financing | -48 | -35 | -31 |
| Capex | 19 | 50 | 42 |
| Free cash flow | 49 | 17 | 39 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| ROE % | 21.9% | 20.1% | 15.7% |
| ROCE % | 32.5% | 27.9% | 22.1% |
| Debtor days | 22 | 22 | 16 |
| Inventory days | 36 | 41 | 43 |
| Payable days | 164 | 161 | 170 |
| Cash conversion cycle (days) | -106 | -98 | -111 |
| Working capital days | 3 | 4 | 8 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 65.57% |
| FIIs | 3.00% |
| DIIs | 7.10% |
| of which Mutual funds | 4.61% |
| Public (non-institutions) | 24.32% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% |
| Promoter group | % |
|---|---|
| GPT Sons Private Limited | 65.57% |
| Om Tantia | 0.00% |
| Shree Gopal Tantia | 0.00% |
| Aruna Tantia | 0.00% |
| Pramila Tantia | 0.00% |
| Vinita Tantia | 0.00% |
| Atul Tantia | 0.00% |
| Vaibhav Tantia | 0.00% |
| Atul Tantia HUF | 0.00% |
| Nirmala Sureka | 0.00% |
| Ishwari Prasad Tantia | 0.00% |
| Pawan Kumar Bagaria | 0.00% |
| Pawan Kumar Bagaria HUF | 0.00% |
| Ishwari Prasad Tantia HUF | 0.00% |
| Anurag Tantia | 0.00% |
| Public holders above 1% | % |
|---|---|
| Bandhan Small Cap Fund | 4.61% |
| India Capital Growth Fund Limited | 2.74% |
| Rajasthan Global Securities Private Limited | 1.20% |
59,151 shareholders. Pledged: – of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| GPTHEALTH | ₹1,066 cr | 22.6x | 4.0x | 18.3% | 24.4% | 18.5% | – | 1.92% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-30 | Dividend | Dividend - Rs1.50 Per Share |
| 2025-11-14 | Dividend | Interim Dividend - Re 1 Per Share |
| 2025-07-29 | Dividend | Dividend - Rs 1.50 Per Share |
| 2024-11-28 | Dividend | Interim Dividend - Re 1 Per Share |
| 2024-07-18 | Dividend | Annual General Meeting/Dividend - Rs 1.50 Per Share |
| 2024-04-02 | Dividend | Interim Dividend - Re 1 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | GPTHEALTH |
| BSE code | 544131 |
| ISIN | INE486R01017 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.